NFKB1 and colitis: In summary, our data indicated that CK exerts effient therapy effects on DSS-induced progression of colitis in mice, and the potential mechanisms for regulating this intestinal inflammation may contribute to regulating the innate immune cells such as macrophages activities through modulating of NF-κB signaling pathways activation that dominate the production of cytokines and chemokines.